Patent Infringement Settlement and License Agreement Sample Contracts

Neptune and Aker BioMarine Reach Patent Infringement Settlement and License Agreement

Patent Infringement Settlement and License Agreement • December 17th, 2013 • Neptune Technologies & Bioressources Inc. • Pharmaceutical preparations

• Contract Type
  Patent Infringement Settlement and License Agreement
• Filed
  December 17th, 2013
• Company
  Neptune Technologies & Bioressources Inc.
• Industry
  Pharmaceutical preparations

LAVAL, Quebec, Dec. 17, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX:NTB), Acasti Pharma Inc. ("Acasti") (Nasdaq:ACST) (TSX-V:APO), a Neptune subsidiary, and Aker BioMarine AS, Aker BioMarine Antarctic AS and Aker BioMarine Antarctic USA (collectively "AKBM") jointly announce a settlement and license agreement that will result in the dismissal of all AKBM respondents from the on-going ITC investigation brought by Neptune and Acasti, as well as the dismissal of all current lawsuits brought by Neptune against AKBM and companies in its value chain.